NASDAQ:SNSS - Sunesis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$0.68 -0.01 (-1.45 %)
(As of 01/17/2019 01:24 AM ET)
Previous Close$0.68
Today's Range$0.62 - $0.68
52-Week Range$0.20 - $7.69
Volume62,700 shs
Average Volume413,155 shs
Market Capitalization$26.38 million
P/E Ratio-0.47
Dividend YieldN/A
Beta2.57

Analyst Ratings

Sunesis Pharmaceuticals (NASDAQ:SNSS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Sunesis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $2.25, suggesting that the stock has a possible upside of 230.88%. The high price target for SNSS is $4.00 and the low price target for SNSS is $0.50. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.002.002.602.60
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.25$4.00$4.4933$4.4933
Price Target Upside: 230.88% upside51.52% upside70.20% upside70.20% upside

Sunesis Pharmaceuticals (NASDAQ:SNSS) Consensus Price Target History

Price Target History for Sunesis Pharmaceuticals (NASDAQ:SNSS)

Sunesis Pharmaceuticals (NASDAQ:SNSS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/20/2018HC WainwrightInitiated CoverageNeutral ➝ Neutral$0.50HighView Rating Details
5/8/2018CowenReiterated RatingHoldHighView Rating Details
3/8/2018Cantor FitzgeraldReiterated RatingHold$4.00HighView Rating Details
12/14/2017OppenheimerInitiated CoverageBuy$7.00LowView Rating Details
12/11/2017Wells Fargo & CoUpgradeMarket Perform ➝ Outperform$2.86 ➝ $2.48HighView Rating Details
11/20/2017UBS GroupInitiated CoverageOutperformN/AView Rating Details
(Data available from 1/17/2017 forward)
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel